New Dawn Psychiatric Care

New Dawn Psychiatric Care in Bellevue, Washington offers Spravato esketamine, an FDA-approved treatment for adults with treatment-resistant depression and depression with acute suicidal thoughts. Used alongside an oral antidepressant, Spravato acts on glutamate pathways linked to mood, cognition, and emotional flexibility, offering a new path for those who have not found relief with standard medications.

Care begins with a comprehensive psychiatric evaluation and insurance authorization. Spravato is then self-administered as a nasal spray in a private treatment space, followed by at least two hours of monitoring. Initial treatment involves two sessions per week for four weeks, then a gradual taper based on response, and patients need a ride home afterward.

The practice also offers NeuroStar TMS, medication management, lifestyle strategies, and therapy under one roof, with both in-person and virtual options.